The Primate Corticospinal Connectome and Transcriptome

灵长类动物皮质脊髓连接组和转录组

基本信息

  • 批准号:
    10650134
  • 负责人:
  • 金额:
    $ 63.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Efforts to promote recovery of function after human spinal cord injury (SCI) will likely require interventions targeting the corticospinal motor system, the most important pathway for voluntary motor control in humans. In a series of studies over the past 4 years we have found that corticospinal tract (CST) axons regenerate into spinal cord neural stem cell (NSC) grafts placed into sites of SCI in mice, rats and monkeys. These regenerating CST axons form synapses with the graft, and the graft in turn extends very large numbers of new axons from the injury site over long distances into the distal spinal cord. Neural relays across the injury are thereby formed, supporting functional improvement. This work is on a human translational path and IND-enabling work is in progress. This grant proposes two new directions that will be critically important in supporting human translation. First, we recently reported that injured adult mouse CST neurons revert to an embryonic transcriptional state that lasts for two weeks after SCI, a time during which CST axons can regenerate. This finding establishes a critical period for intervention after mouse SCI to support recovery. Does the same transcriptional reversion to a pro-growth embryonic state occur in the primate brain? If so, how long does it last? Work in Aim 1 will definitively answer this question, identifying for the first time what may be an optimal time window for therapeutic intervention of any type to support functional recovery in primates, including humans. We will perform RNA sequencing (RNAseq) specifically of CST neurons after SCI in rhesus monkeys using intersectional viral approaches, based on supportive preliminary data in monkeys. In Aim 2 we propose for the first time using novel viral vectors to anterogradely, trans-synaptically trace primate corticospinal projections to the spinal cord. Our preliminary studies demonstrate that rodent CST axons project nearly entirely to spinal cord interneurons, whereas in primates the vast preponderance of CST axons terminate directly on alpha motor neurons. Knowing the precise targets of CST projections to the spinal cord will both markedly extend our basic knowledge of motor system organization in primates, and will allow optimization of stem cell graft properties to enhance neural relay formation across sites of SCI. Unlike other neural stem cell programs for SCI, our work aims to directly re-form critical neural relays across a severe injury, rather than target spared axons through grafts of OPCs; knowledge gained from this aim could markedly improve relay formation across injury sites in the primate system.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK H. TUSZYNSKI其他文献

MARK H. TUSZYNSKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK H. TUSZYNSKI', 18)}}的其他基金

Advancing human neural progenitor cells (hNPCs) to FDA IND approval
推动人类神经祖细胞 (hNPC) 获得 FDA IND 批准
  • 批准号:
    10642228
  • 财政年份:
    2023
  • 资助金额:
    $ 63.09万
  • 项目类别:
The Primate Corticospinal Connectome and Transcriptome - Supplement
灵长类动物皮质脊髓连接组和转录组 - 补充
  • 批准号:
    10876189
  • 财政年份:
    2023
  • 资助金额:
    $ 63.09万
  • 项目类别:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
AAV2-BDNF 基因治疗阿尔茨海默病的临床试验
  • 批准号:
    10663796
  • 财政年份:
    2021
  • 资助金额:
    $ 63.09万
  • 项目类别:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
AAV2-BDNF 基因治疗阿尔茨海默病的临床试验
  • 批准号:
    10185291
  • 财政年份:
    2021
  • 资助金额:
    $ 63.09万
  • 项目类别:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
AAV2-BDNF 基因治疗阿尔茨海默病的临床试验
  • 批准号:
    10402369
  • 财政年份:
    2021
  • 资助金额:
    $ 63.09万
  • 项目类别:
ShEEP request for a Zeiss LSM 880 with Airyscan confocal system
ShEEP 请求配备 Airyscan 共焦系统的 Zeiss LSM 880
  • 批准号:
    9573958
  • 财政年份:
    2018
  • 资助金额:
    $ 63.09万
  • 项目类别:
The Primate Corticospinal Connectome and Transcriptome
灵长类动物皮质脊髓连接组和转录组
  • 批准号:
    10386916
  • 财政年份:
    2017
  • 资助金额:
    $ 63.09万
  • 项目类别:
The Primate Corticospinal Connectome and Transcriptome
灵长类动物皮质脊髓连接组和转录组
  • 批准号:
    10211059
  • 财政年份:
    2017
  • 资助金额:
    $ 63.09万
  • 项目类别:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
RR
  • 批准号:
    10538563
  • 财政年份:
    2015
  • 资助金额:
    $ 63.09万
  • 项目类别:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
RR
  • 批准号:
    9822285
  • 财政年份:
    2015
  • 资助金额:
    $ 63.09万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 63.09万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 63.09万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 63.09万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 63.09万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了